Related Experiment Video
Updated: Jun 22, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
The Role of Lipoprotein(a) in Peripheral Artery Disease
Nicholas Pavlatos1, Dinesh K Kalra2
1Department of Internal Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Insights
Elevated Lipoprotein(a) [Lp(a)] is a significant risk factor for cardiovascular disease. This review explores Lp(a)
Area of Science:
- Cardiovascular Medicine
- Lipidology
- Genetics
Background:
- Lipoprotein(a) [Lp(a)] is a particle structurally similar to low-density lipoprotein, comprising apolipoprotein(a) and apolipoprotein(b).
- Elevated Lp(a) is a recognized causal risk factor for atherosclerotic cardiovascular disease, stroke, and aortic valve stenosis.
- Despite its prevalence (20% of the global population), Lp(a) testing is underutilized due to low awareness and limited therapeutic options.
Purpose of the Study:
- To review the epidemiology, biology, and pathogenesis of Lp(a) concerning peripheral artery disease (PAD).
- To discuss emerging therapeutic strategies for mitigating adverse cardiovascular and limb events in patients with elevated Lp(a).
Main Methods:
- Literature review focusing on the association between Lp(a) and PAD.
- Analysis of epidemiological data, biological mechanisms, and pathogenic pathways.
- Examination of current and emerging treatment modalities.
Main Results:
- Lp(a) has a strong link to coronary artery disease and cerebrovascular disease.
- The relationship between Lp(a) and peripheral artery disease (PAD) is less well-established but warrants further investigation.
- Emerging therapies aim to reduce Lp(a) levels and associated cardiovascular and limb risks.
Conclusions:
- Understanding the role of Lp(a) in PAD is crucial for comprehensive cardiovascular risk assessment.
- Increased awareness and improved testing for Lp(a) are needed.
- Novel therapies hold promise for managing Lp(a)-associated cardiovascular and limb events.
Abstract:
Lipoprotein(a) is a low-density-lipoprotein-like particle that consists of apolipoprotein(a) bound to apolipoprotein(b). It has emerged as an established causal risk factor for atherosclerotic cardiovascular disease, stroke, and aortic valve stenosis through multifactorial pathogenic mechanisms that include inflammation, atherogenesis, and thrombosis. Despite an estimated 20% of the global population having elevated lipoprotein(a) levels, testing remains underutilized due to poor awareness and a historical lack of effective and safe therapies. Although lipoprotein(a) has a strong association with coronary artery disease and cerebrovascular disease, its relationship with peripheral artery disease is less well established. In this article, we review the epidemiology, biology, and pathogenesis of lipoprotein(a) as it relates to peripheral artery disease. We also discuss emerging treatment options to help mitigate major adverse cardiac and limb events in this population.
More Related Videos
Related Concept Videos
Inflammation
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

